EUVIMEDEUVIMED entdecken
Crossref

Discovery and Characterization of Novel Receptor-Interacting Protein Kinase 1 Inhibitors Using Deep Learning and Virtual Screening

Bo Liu, Likun Zhao, Yi Tan, Xiaojun Yao iD, Huanxiang Liu iD, Qianqian Zhang iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Bo Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Applied Sciences, Macao Polytechnic University, Macao SAR 999078, China. Hauptthemen laut MEDLINE: Deep Learning, Receptor-Interacting Protein Serine-Threonine Kinases, Protein Kinase Inhibitors, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Receptor-interacting protein kinase 1 (RIPK1) serves as a critical mediator of cell necroptosis and represents a promising therapeutic target for various human neurodegenerative diseases and inflammatory diseases. Nonetheless, the RIPK1 inhibitors currently reported are inadequate for clinical research due to suboptimal inhibitory activities or lack of selectivity. Consequently, there is a need for the discovery of novel RIPK1 kinase inhibitors. In this study, we integrated a deep learning model, specifically the fingerprint graph attention network (FP-GAT), with molecular docking-based virtual screening to identify potential RIPK1 inhibitors from a library comprising 13 million compounds. Out of 43 compounds procured, two compounds (designated as 24 and 41) demonstrated enzyme inhibition activity exceeding 50% at a concentration of 10 μM against RIPK1. The half-maximal inhibitory concentrations (IC50) for compounds 24 and 41 were determined to be 2.01 and 2.95 μM, respectively. Furthermore, these compounds exhibited protective effects in an HT-29 cell model of TSZ-induced necroptosis, with half-maximal effective concentrations (EC50) of 6.77 μM for compound 24 and 68.70 μM for compound 41. Finally, molecular dynamics simulations and binding free energy calculations were conducted to elucidate the molecular mechanism of compounds 24 and 41 binding to RIPK1. The results show that Met92, Met95, Ala155, and Asp156 are key residues for novel RIPK1 inhibitors. In summary, this work discovered two hit compounds targeting RIPK1, which can be further structurally modified to become promising lead compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningReceptor-Interacting Protein Serine-Threonine KinasesProtein Kinase InhibitorsDrug DiscoveryHumansMolecular Docking SimulationHT29 CellsNecroptosisDrug Evaluation, Preclinical

Stichwörter der Autor:innen

RIPK1 inhibitordeep learningmolecular dynamics simulationvirtual screening

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesProtein Kinase InhibitorsRIPK1 protein, human

Autor:innen und Institutionen

  • Faculty of Applied Sciences, Macao Polytechnic University, Macao SAR 999078, China.

ORCID-Profile: Xiaojun Yao, Huanxiang Liu, Qianqian Zhang

Förderung

  • Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia

Zitieren

APA

Liu, B., Zhao, L., Tan, Y., Yao, X., Liu, H., & Zhang, Q. (2025). Discovery and Characterization of Novel Receptor-Interacting Protein Kinase 1 Inhibitors Using Deep Learning and Virtual Screening. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00180

Vancouver

Liu B, Zhao L, Tan Y, Yao X, Liu H, Zhang Q. Discovery and Characterization of Novel Receptor-Interacting Protein Kinase 1 Inhibitors Using Deep Learning and Virtual Screening. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00180

BibTeX
@article{Liu2025,
  author = {Liu, Bo and Zhao, Likun and Tan, Yi and Yao, Xiaojun and Liu, Huanxiang and Zhang, Qianqian},
  title = {Discovery and Characterization of Novel Receptor-Interacting Protein Kinase 1 Inhibitors Using Deep Learning and Virtual Screening},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00180}
}
Kostenlos starten →